MedPath
HSA Approval

POLYSILIC III SUSPENSION

SIN03406P

POLYSILIC III SUSPENSION

POLYSILIC III SUSPENSION

June 16, 1989

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBEACONS PHARMACEUTICALS PTE. LTD.
Licence HolderBEACONS PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

SUSPENSION

ORAL

Medical Information

A02AF02

ordinary salt combinations and antiflatulents

Manufacturer Information

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE LTD

Active Ingredients

SIMETHICONE

30 mg/5 ml

Simethicone

MAGNESIUM TRISILICATE LIGHT

400 mg/5 ml

Magnesium trisilicate

ALUMINIUM HYDROXIDE (DRIED GEL)

400 mg/5 ml

Aluminum hydroxide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

POLYSILIC III SUSPENSION - HSA Approval | MedPath